Academia Sinica yesterday said that its researchers have developed an antibody testing method for COVID-19 and have made progress synthesizing remdesivir, a medicine that many believe could cure the infection.
The Centers for Disease Control on Tuesday sent serum samples to Academia Sinica of three people who had contact with Taiwan’s first COVID-19 fatality, as part of an effort to determine the source of that infection.
The three had tested negative for RNA viruses, but the centers hoped to discover if they had developed antibodies.
Photo courtesy of Academia Sinica
Test results showed that only one sample had antibodies for COVID-19 and SARS, Academia Sinica Institute of Biomedical Sciences research fellow Lin Yi-ling (林宜玲) said.
The sample was obtained from a Taiwanese businessperson who was not listed as a confirmed case, because their immune system beat the virus, she said.
Little is known about COVID-19, so it is still a mystery whether a person who has recovered from it can contract it again, she added.
The method is useful in tracing the transmission chain of a certain case, Institute of Plant and Microbial Biology Director Wu Shu-hsing (吳素幸) said, but added that testing for RNA viruses tells whether a person contracts COVID-19.
Using molecular biology and genetic engineering, Wu said that she pieced together plasmids — a kind of DNA for expressing antigens — in small templates to make up longer series of plasmids for producing the antigens used to test for COVID-19, SARS and Middle East respiratory syndrome antibodies.
Ordering massive plasmid series from overseas manufacturers takes two to three weeks, Lin said, praising Wu’s team for only needing a week.
After Institute of Biological Chemistry associate research fellow Ho Meng-chiao (何孟樵) purified the nucleocapsid protein of COVID-19 for making reagents, Lin used the western blot method to place the antigens in a serum sample for testing antibody reactions, she said.
Another team led by Institute of Chemistry associate research fellow Chein Rong-jie (陳榮傑) succeeded in synthesizing 100mg of remdesivir in two weeks.
Unable to obtain the raw materials in time, they used materials on hand and molecule synthesis, referencing public-domain literature, to make the drug, which on Thursday was 97 percent as pure as the original, Chein said.
Before the centers tasked them with the mission, Academia Sinica President James Liao (廖俊智) last month formed a task force to speed up the development of antigens, antibodies, drugs and vaccines for COVID-19.
The synthesized drug cannot be used without the consent of the US pharmaceutical firm that manufactures remdesivir, Liao said.
Nonetheless, the achievement showed that Academia Sinica is capable of drug synthesis and could facilitate mass production of the drug after a technology transfer has been completed, he added.
LEVERAGE: China did not ‘need to fire a shot’ to deny Taiwan airspace over Africa when it owns ‘half the continent’s debt,’ a US official said, calling it economic warfare The EU has raised concerns about overflight rights following the delay of President William Lai’s (賴清德) planned state visit to the Kingdom of Eswatini after three African nations denied overflight clearance for his charter at the last minute. Taiwanese allies Paraguay and Saint Kitts and Nevis, as well as several US lawmakers and the Inter-Parliamentary Alliance on China (IPAC) condemned China for allegedly pressuring the countries. Lai was scheduled to fly directly to Taiwan’s only African ally from yesterday to Sunday to celebrate the 40th anniversary of King Mswati III’s accession and his 58th birthday, but Seychelles, Mauritius and Madagascar suddenly revoked
The final batch of 28 M1A2T Abrams tanks purchased from the US arrived at Taipei Port last night and were transported to the Armor Training Command in Hsinchu County’s Hukou Township (湖口), completing the military’s multi-year procurement of 108 of the tanks. Starting at 12:10am today, reporters observed more than a dozen civilian flatbed trailers departing from Taipei Port, each carrying an M1A2T tank covered with black waterproof tarps. Escorted by military vehicles, the convoy traveled via the West Coast Expressway to the Armor Training Command, with police implementing traffic control. The army operates about 1,000 tanks, including CM-11 Brave Tiger
China on Wednesday teased in a video an aircraft carrier that could be its fourth, and the first using nuclear power, while making an allusion to Taiwan and vowing to further build up its islands, as it looks to boost maritime power, secure resources and bolster territorial claims. The video, issued on the eve of the 77th founding anniversary of the Chinese People’s Liberation Army Navy, featured fictional officers with names that are homophones of three commissioned aircraft carriers, the Liaoning (遼寧), Shandong (山東) and Fujian (福建). Titled Into the Deep, it showed a 19-year-old named “Hejian” (何劍) joining the group, sparking
BIG YEAR: The company said it would also release its A12 chip the same year to keep a ‘reliable stream of new silicon technologies’ flowing to its customers Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday said its newest A13 chip is to enter volume production in 2029 as the chipmaker seeks to hold onto its tech leadership and demand for next-generation chips used in artificial intelligence (AI), high-performance-computing (HPC) and mobile applications. TSMC, the world’s biggest contract chipmaker, also unveiled its A12 chip at its annual technology symposium in Santa Clara, California. The A12 chip, which features TSMC’s super-power-rail technology to provide backside power delivery for AI and HPC applications, is also to enter volume production in 2029, a year after the scheduled release of the A14 chip. The technology moves
RSS